Tous Actualités
Suivre
Abonner Deutsche Effecten- und Wechsel-Beteiligungsges. AG

Deutsche Effecten- und Wechsel-Beteiligungsges. AG

euro adhoc: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Capital measures
DEWB AG resolves to issue a convertible bond

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
12.09.2007
The Management Board of Deutschen Effecten- und 
Wechsel-Beteiligungsgesellschaft AG (DEWB) has today resolved, with 
the consent of the Supervisory Board, to issue a convertible bond in 
the total nominal sum of up to 20,000,000 euros. The company is 
therefore making partial use of the authorization granted by the 
Annual General Meeting dated May 26, 2004 which remains in force up 
to May 25, 2009.
The convertible bond will have a maturity of 5 years, with a coupon 
of 6.0 percent and a conversion price of 3.20 euros. This corresponds
to a conversion premium of approx. 25 percent based on the average 
closing price of the DEWB share on the XETRA of 2.55 euros. The 
convertible bond is to be divided into up to 20,000 part convertible 
bonds each with a nominal value of 1,000 euros. The conversion ratio,
i.e. the amount of shares to be delivered in case of a conversion, 
results from the division of the nominal value by the conversion 
price. The bond is expected to be offered to DEWB shareholders for 
subscription from September 17, to October 1, 2007 within the 
framework of a subscription rights issue. For each 1,523 shares two 
part convertible bonds can be purchased at the price of 1,000 EUR 
each. No public offering will be made. Part convertible bonds not 
subscribed by shareholders will be offered by quirin bank AG to 
institutional investors under the same terms and conditions. The 
issue will be assisted by quirin bank AG and Close Brothers Seydler 
AG.
The main terms and conditions of the convertible bond will be 
notified to the company´s shareholders by way of a subscription 
offer. The subscription offer is expected to be published on Thursday
September 13, 2007 on the company´s Homepage and in the 
"Börsenzeitung" as well as on Friday September 14, 2007 in the 
electronic "Federal Gazette" (Bundesanzeiger). The definitive bond 
conditions can be obtained from the company (Leutragraben 1, D-07743 
Jena) and quirin bank AG (Kurfürstendamm 119, D-10711 Berlin) and are
also available at www.dewb-vc.com.
The proceeds from the issue are to be used to increase the company´s 
investment funds in order to make future investments independent of 
the inflows from investment sales from the timing aspect and 
consequently enable it to take advantage of an increasing number of 
investment opportunities.
end of announcement                               euro adhoc 12.09.2007 19:56:12

Further inquiry note:

Mirko Wäckerle
Tel.: +49 (0) 3641 573-3600
E-Mail: ir@dewb-vc.com

Branche: Financial & Business Services
ISIN: DE0008041005
WKN: 804100
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse München / free trade

Plus de actualités: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Plus de actualités: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
  • 23.08.2007 – 16:09

    DEWB sells its stake in EPIDAUROS Biotechnologie AG to Clinical Data B.V.

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies Jena (euro adhoc) - DEWB AG, Jena, has sold its 75.4 percent stake in EPIDAUROS Biotechnologie AG (Epidauros), Bernried. The buyer is Clinical Data B.V. based in Spankeren, the Netherlands. Clinical Data B.V. is the European subsidiary of the ...

  • 08.08.2007 – 10:48

    bm-t and DEWB acquire majority shareholding in Zenteris

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. merger, acquisition and takeover Erfurt/Jena (euro adhoc) - bm-t beteiligungsmanagement thüringen gmbh (bm-t), Erfurt and Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB), Jena took a joint stake in Zenteris GmbH (Zenteris) at the end of July 2007. In an initial round of financing, ...